Overview of Cell-Based Assays Market Growth According to MarketsandMarkets

Wednesday, 11 September 2024, 07:29

MarketsandMarkets reports the cell-based assays market is poised to grow from USD 17.3 billion in 2024 to USD 24.3 billion by 2029, driven by increasing demand for personalized medicine and drug development. This growth reflects a compound annual growth rate (CAGR) of 7.1%, indicating a substantial shift in biotechnological advancements.
LivaRava_Medicine_Default.png
Overview of Cell-Based Assays Market Growth According to MarketsandMarkets

Market Growth Prediction

The cell-based assays market is witnessing remarkable growth, with projections showing an increase from USD 17.3 billion in 2024 to USD 24.3 billion by 2029. This represents a robust CAGR of 7.1%.

Driving Factors

  • Rising Demand: The growing need for personalized medicine is a key driver.
  • Technological Advancements: Innovations in biotechnology are enhancing assay efficacy.
  • Increased investments in drug development.

Conclusion: Significant Market Trends

Overall, the cell-based assays market is expected to experience sustained growth, attributing to the rising biopharmaceutical sector and an increased focus on effective therapeutic solutions.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe